Adverse event
An unfavorable medical occurrence during a study; it is not automatically caused by the intervention.
Search peptides, goals, protocols and references
09 · FEMETRIC REFERENCE
An unfavorable medical occurrence during a study; it is not automatically caused by the intervention.
A quantitative test estimating the amount or potency of a substance in a sample.
The rate and extent at which an active substance reaches systemic circulation.
Keeping participants, investigators or assessors unaware of treatment assignment to reduce bias.
A prospective study in human participants designed to answer a health-related intervention question.
Certificate of analysis: a lot-specific report of tests, acceptance criteria and results.
A range describing uncertainty around an estimated effect.
Amount of substance per unit volume, commonly expressed as mg/mL or mcg/mL.
A prespecified outcome used to evaluate an intervention.
Bacterial lipopolysaccharide measured separately from identity, purity and sterility.
A temporary departure from a product's labeled storage conditions.
The specific composition and dosage form of a product; blend names alone may not define one.
Research performed in cells, tissues or another controlled environment outside a living organism.
Under study and not established as approved for the described use.
Laboratory or animal research conducted before or outside human clinical trials.
The original study report, trial registry, regulator document or product label.
The measured proportion of the primary substance relative to detected material under a stated method.
Assignment by chance to study groups to reduce systematic differences.
How a substance is administered, such as oral, subcutaneous or intravenous.
An event meeting defined seriousness criteria such as hospitalization or life threat; seriousness differs from severity.
Absence of viable contaminating microorganisms under a validated test; it is not shown by purity.
A syringe calibration in which 100 marked units correspond to 1 mL of volume.